Relmada Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $253k | 61k | 4.14 |
| 2023-09-30 | $262k | 87k | 3.00 |
| 2023-06-30 | $257k | 105k | 2.46 |
| 2023-03-31 | $249k | 110k | 2.26 |
| 2022-12-31 | $414k | 119k | 3.49 |
| 2022-09-30 | $1.3M | 34k | 37.02 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management